2022

1. Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease

   European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 222-227

2. Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients

   European Journal of Pharmaceutical Sciences, Vol. 168